Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Cost implications of development of diabetes in the ALPINE studyLars H Lindholm, Bernt Kartman, Bo Carlberg, et al.Journal of Hypertension|July 23, 2003
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)Lars H Lindholm, Mats Persson, Petar Alaupovic, et al.Blood Pressure|April 21, 2017
The Outcome of STOP-Hypertension-2 in Relation to the 1999 WHO/ISH Hypertension GuidelinesLars H LindholmCurrent Opinion in Lipidology|June 11, 2009
Dyslipidemia of kidney diseasePer-Ola Attman, Ola SamuelssonLakartidningen|June 14, 2019
[Severe COPD can benefit from endobronchial valves]Gerdt Riise, Therese Svanberg, Ola SamuelssonLancet (London, England)|November 9, 2004
Atenolol in hypertension: is it a wise choice?Bo Carlberg, Ola Samuelsson, Lars Hjalmar LindholmNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2011
The effect of decreasing renal function on lipoprotein profilesPer-Ola Attman, Ola Samuelsson, Petar AlaupovicLancet (London, England)|November 1, 2005
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysisLars Hjalmar Lindholm, Bo Carlberg, Ola SamuelssonEvaluation and Program Planning|June 27, 2015
Early assessment of implementing evidence-based brief therapy interventions among secondary service psychiatric therapistsLars H Lindholm, Antti Koivukangas, Antero Lassila, et al.Journal of Hypertension|April 27, 2004
Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policyMats Persson, Bo Carlberg, Björn Tavelin, et al.Pageof 10